Status:
TERMINATED
Metabolism of Lipids in Advanced Cancer
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Lung Neoplasms
Cachexia
Eligibility:
All Genders
18-85 years
Brief Summary
The causes of failing nutrition status in advanced cancer are not well known. The way fat is moved, stored, burned or changed into other compounds may be affected and will be followed in patients usin...
Detailed Description
Weight loss in cancer is the result of breakdown of fat (lipid) and muscle protein reserves. This research will explore how people with cancer use fat in their body through the use of tracers and meas...
Eligibility Criteria
Inclusion
- Low plasma phospholipids OR low plasma ratio of triglycerides to free fatty acids
- Recent weight loss
- Advanced stage lung cancer (Stage 3 or 4)
Exclusion
- Having symptoms that may affect measures of fat metabolism (nausea, vomiting, problems swallowing, etc.)
- Taking n-3 fatty acid supplements such as fish oil
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00962234
Start Date
October 1 2009
End Date
October 1 2011
Last Update
February 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2